Hybrid channels containing the dupα7 subunit mediate resistance to α7-nAChR targeting therapy in metastatic melanoma
American Journal of Physiology-Cell Physiology · 2026
DOI: 10.1152/ajpcell.00730.2025 ↗Kurz gefasst
Fachartikel in der Zeitschrift American Journal of Physiology-Cell Physiology, 2026. Verfasst von Artem V Kirichenko und 16 weiteren Autor:innen. Beteiligte Einrichtung: Shemyakin-Ovchinnikov Institute of Bioorganic Chemistry, Russian Academy of Sciences, Moscow, Russia. Hauptthemen laut MEDLINE: alpha7 Nicotinic Acetylcholine Receptor, Melanoma, Drug Resistance, Neoplasm, Urokinase-Type Plasminogen Activator. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 83 Literaturangaben. Gefördert von: Russion Science Foundation, International Partnership Program of the Chinese Academy of Sciences, Ministry of Education of Guangdong Province of China.
Abstract (Originalsprache)
Metastatic melanoma is aggressive skin tumor often resistant to standard therapies. High α7-nAChR expression negatively correlates with survival of patients with metastatic melanoma, who are characterized by SLURP-1 drop in the plasma. Targeting α7-nAChR with recombinant SLURP-1 could significantly suppress metastatic melanoma cell migration; however, overexpression of human-specific dupα7 subunit forming hybrid α7/dupα7-nAChRs causes melanoma resistance to SLURP-1. This resistance can be overcome by the SLURP-1 mimicking peptide Oncotag, which exhibits activity against hybrid α7/dupα7-nAChRs.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Shemyakin-Ovchinnikov Institute of Bioorganic Chemistry, Russian Academy of Sciences, Moscow, Russia.
- Moscow Center for Advanced Studies, Moscow, Russia.
- Biological Department, Shenzhen MSU-BIT University, Shenzhen, People's Republic of China.
- Faculty of Biology, Lomonosov Moscow State University, Moscow, Russia.
- N.N. Blokhin National Medical Research Center of Oncology, Ministry of Health of Russia, Moscow, Russia.
- V.F. Voyno-Yasenetsky Krasnoyarsk State Medical University, Krasnoyarsk, Russia.
ORCID-Profile: Artem V Kirichenko, Maxim L Bychkov, Olga V Shlepova, Philipp S Orekhov, Alexander S Paramonov, Igor A Medyanik, Konstantin S Yashin, Zakhar O Shenkarev, Ekaterina N Lyukmanova
Förderung
- Russion Science Foundation
- International Partnership Program of the Chinese Academy of Sciences
- Ministry of Education of Guangdong Province of China
Zitieren
APA
Kirichenko, A. V., Bychkov, M. L., Kulbatskii, D. S., Shlepova, O. V., Shulepko, M. A., Gornostaeva, T. Y., Orekhov, P. S., Paramonov, A. S., Mikhaylova, I. N., Burova, O. S., Medyanik, I. A., Yashin, K. S., Wang, H., Wang, X., Kirpichnikov, M. P., Shenkarev, Z. O., & Lyukmanova, E. N. (2026). Hybrid channels containing the dupα7 subunit mediate resistance to α7-nAChR targeting therapy in metastatic melanoma. American Journal of Physiology-Cell Physiology. https://doi.org/10.1152/ajpcell.00730.2025
Vancouver
Kirichenko AV, Bychkov ML, Kulbatskii DS, Shlepova OV, Shulepko MA, Gornostaeva TY, et al. Hybrid channels containing the dupα7 subunit mediate resistance to α7-nAChR targeting therapy in metastatic melanoma. American Journal of Physiology-Cell Physiology. 2026. doi:10.1152/ajpcell.00730.2025
BibTeX
@article{Kirichenko2026,
author = {Kirichenko, Artem V and Bychkov, Maxim L and Kulbatskii, Dmitry S and Shlepova, Olga V and Shulepko, Mikhail A and Gornostaeva, Tamara Ya and Orekhov, Philipp S and Paramonov, Alexander S and Mikhaylova, Irina N and Burova, Olga S and Medyanik, Igor A and Yashin, Konstantin S and Wang, Hongshuang and Wang, Xiaohui and Kirpichnikov, Mikhail P and Shenkarev, Zakhar O and Lyukmanova, Ekaterina N},
title = {Hybrid channels containing the dupα7 subunit mediate resistance to α7-nAChR targeting therapy in metastatic melanoma},
journal = {American Journal of Physiology-Cell Physiology},
year = {2026},
doi = {10.1152/ajpcell.00730.2025}
}
EUVIMED